ArticleJournal of diabetes investigation2021

Body-weight-independent glucose-lowering effect of the β3-adrenergic receptor agonist mirabegron in humans.

Hironori Waki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.